Login or sign up
For business

Jericho sciences, llc

4.0· 8 reviews
Average ratingGreat
4.0/ 5

Based on 8 reviews

525%
450%
325%
20%
10%
Efrem Venters
Reviews 1

I recently utilized the services of a company for my scientific research project. They provided me with exceptional support and guidance throughout the process. The team was very helpful and responsive. Their expertise and attention to detail greatly contributed to the success of my project.

Lucia Muros
Reviews 1

Jericho sciences, llc is an innovative company in the field of science and technology. Their expertise and dedication are commendable. The team always goes above and beyond to deliver high-quality solutions. I'm very happy with their services and would highly recommend them to others.

Jason Brown
Reviews 1

I had a wonderful experience working with a certain organization recently. They provided excellent support and guidance throughout our collaboration. The team was always available to answer my questions and address any concerns. Their expertise and professionalism are top-notch.

Betty Postlewait
Reviews 1

I recently had the opportunity to work with a certain company, and I must say, they were amazing. The team was extremely professional and efficient. They provided excellent support and delivered high-quality results. I couldn't be happier with their services.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About Jericho sciences, llc

Jericho Sciences, LLC is focused on research and development of novel antiviral therapeutic and diagnostic products. Thier lead candidate compound exerts action via a viral peptide motif shared by many types of viruses, including human immunodeficiency virus (HIV-1) and feline immunodeficiency virus (FIV). While current combination antiretroviral therapy (cART) regimens can minimize disease progression by reducing viral loads for HIV-infected individuals, they do not address challenges posed by persistent viral reservoirs, therapeutically elusive physiological compartments and the development of drug resistance. New therapeutic agents useful to reduce persistent and elusive virus represent the next evolution for HIV treatment. Jericho Sciences collaborates with academic, government and industrial researchers and maintains a strong intellectual property position for all portfolio projects.

Address
111 10th avenue south
Categories
Research